Biolife Solutions Inc’s filing revealed that its EVP & Chief Scientific Officer Mathew Aby J. unloaded Company’s shares for reported $0.53 million on Nov 15 ’24. In the deal valued at $21.17 per share,25,000 shares were sold. As a result of this transaction, Mathew Aby J. now holds 302,046 shares worth roughly $7.86 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Mathew Aby J. sold 17,604 shares, generating $352,960 in total proceeds. Upon selling the shares at $20.05, the EVP & Chief Scientific Officer now owns 284,442 shares.
Before that, Berard Todd sold 91 shares. Biolife Solutions Inc shares valued at $2,397 were divested by the Chief Marketing Officer at a price of $26.34 per share. As a result of the transaction, Berard Todd now holds 107,756 shares, worth roughly $2.8 million.
H.C. Wainwright initiated its Biolife Solutions Inc [BLFS] rating to a Buy in a research note published on September 30, 2024; the price target was $29. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in early April with a ‘”a Buy”‘ rating. Craig Hallum began covering BLFS with “Buy” recommendation on July 11, 2023. Oppenheimer revised its rating on April 25, 2022. It rated BLFS as “an Outperform” which previously was an “a Perform”.
Price Performance Review of BLFS
On Friday, Biolife Solutions Inc [NASDAQ:BLFS] saw its stock jump 2.44% to $26.01. Over the last five days, the stock has gained 23.74%. Biolife Solutions Inc shares have risen nearly 60.06% since the year began. Nevertheless, the stocks have risen 91.67% over the past one year. While a 52-week high of $28.88 was reached on 11/13/24, a 52-week low of $11.91 was recorded on 03/01/24. SMA at 50 days reached $24.00, while 200 days put it at $21.32.
Levels Of Support And Resistance For BLFS Stock
The 24-hour chart illustrates a support level at 25.39, which if violated will result in even more drops to 24.76. On the upside, there is a resistance level at 26.35. A further resistance level may holdings at 26.68. The Relative Strength Index (RSI) on the 14-day chart is 58.24, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.90, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 30.50%. Stochastics %K at 63.76% indicates the stock is a holding.
How much short interest is there in Biolife Solutions Inc?
A steep rise in short interest was recorded in Biolife Solutions Inc stocks on 2024-10-31, dropping by 51414.0 shares to a total of 3.5 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 3.55 million shares. There was a decline of -1.47%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on October 19, 2021 when B. Riley Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $61 price target.
